Journal article
Evaluation and Management of Neuroendocrine Tumors of the Pancreas
The Surgical clinics of North America, Vol.99(4), pp.793-814
08/01/2019
DOI: 10.1016/j.suc.2019.04.014
PMCID: PMC6601637
PMID: 31255207
Abstract
Pancreatic neuroendocrine tumors are a diverse group of neoplasms with a generally favorable prognosis. Although they exhibit indolent growth, metastases are seen in roughly 60% of patients. Pancreatic neuroendocrine tumors may produce a wide variety of hormones, which are associated with dramatic symptoms, but the majority are nonfunctional. The diagnosis and treatment of these tumors is a multidisciplinary effort, and management guidelines continue to evolve. This review provides a concise summary of the presentation, diagnosis, surgical management, and systemic treatment of pancreatic neuroendocrine tumors.
Details
- Title: Subtitle
- Evaluation and Management of Neuroendocrine Tumors of the Pancreas
- Creators
- Aaron T. Scott - Roy J. and Lucille A. Carver College of MedicineJames R. Howe - University of Iowa Hospitals and Clinics
- Resource Type
- Journal article
- Publication Details
- The Surgical clinics of North America, Vol.99(4), pp.793-814
- DOI
- 10.1016/j.suc.2019.04.014
- PMID
- 31255207
- PMCID
- PMC6601637
- NLM abbreviation
- Surg Clin North Am
- ISSN
- 0039-6109
- eISSN
- 1558-3171
- Publisher
- Elsevier
- Number of pages
- 23
- Grant note
- CA148062-0 / T32 grant P50 CA174521-01 / SPORE grant P50CA174521 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
- Language
- English
- Date published
- 08/01/2019
- Academic Unit
- Surgery
- Record Identifier
- 9984322938402771
Metrics
17 Record Views